光大彩票导航网站

  • <tr id='hj8FzW'><strong id='hj8FzW'></strong><small id='hj8FzW'></small><button id='hj8FzW'></button><li id='hj8FzW'><noscript id='hj8FzW'><big id='hj8FzW'></big><dt id='hj8FzW'></dt></noscript></li></tr><ol id='hj8FzW'><option id='hj8FzW'><table id='hj8FzW'><blockquote id='hj8FzW'><tbody id='hj8FzW'></tbody></blockquote></table></option></ol><u id='hj8FzW'></u><kbd id='hj8FzW'><kbd id='hj8FzW'></kbd></kbd>

    <code id='hj8FzW'><strong id='hj8FzW'></strong></code>

    <fieldset id='hj8FzW'></fieldset>
          <span id='hj8FzW'></span>

              <ins id='hj8FzW'></ins>
              <acronym id='hj8FzW'><em id='hj8FzW'></em><td id='hj8FzW'><div id='hj8FzW'></div></td></acronym><address id='hj8FzW'><big id='hj8FzW'><big id='hj8FzW'></big><legend id='hj8FzW'></legend></big></address>

              <i id='hj8FzW'><div id='hj8FzW'><ins id='hj8FzW'></ins></div></i>
              <i id='hj8FzW'></i>
            1. <dl id='hj8FzW'></dl>
              1. <blockquote id='hj8FzW'><q id='hj8FzW'><noscript id='hj8FzW'></noscript><dt id='hj8FzW'></dt></q></blockquote><noframes id='hj8FzW'><i id='hj8FzW'></i>

                Company Events

                Company Dynamics

                04-18

                2023

                To the Future, to the New Dorra pharma attends the 88th China International Pharmaceutical API/Intermediates/Packaging/Equipment Trade Fair

                From April 22th to 24th, the 88th China International Pharmaceutical API/Intermediates/Packaging/Equipment Trade Fair (API China) was held successfully in Qingdao Expo City International Exhibition Center.  The Dorr……

                04-29

                2022

                Focus on the target and implement Agile target management through OKR

                In recent years, Dorra’s business type has expanded and business scale has increased rapidly, the strategic development path of the company is clear, and the upgrading of the company's business model is gradually imp……

                09-25

                2020

                【A Good Book】 Reading & sharing series activities -- Share of impression after reading 《Your first leadership job》

                Reading a good book is like making a good friend, the longer the time goes by, the deeper the friendship will be.At the end of July, the second phase of the reading and sharing activities has been launched inside of Dorr……

                07-27

                2020

                Connect with heart - New staff communication meeting

                In order to enhance the communication, to promote the growth and to help the integration of new employees, the HR department of Dorra Pharma decided to build a communication platform for everyone, on July 2, Dorra Pharma……

                04-06

                2020

                Rybelsus? (oral semaglutide) approved for the treatment of adults with type 2 diabetes in the EU

                4 April 2020 - Novo Nordisk today announced that the European Commission (EC) has granted marketing authorisation for Rybelsus? (oral semaglutide), for the treatment of adults with insufficiently controlled type 2 diabet……

                03-29

                2020

                ViiV Healthcare announces first global regulatory approval of CABENUVA; the first complete, long-acting, regimen for the treatment of HIV

                March 20, 2020--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that Health Canada has approved CABENUVA, the first and onl……

                < 1 2 3 4 5 >

                Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 苏ICP备12056923号-1